References
- Meyers BR, Hirshman SZ. Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin. Antimicrob Agents Chemother 1977: 11(1): 118–21
- Fu KP, Neu HC. Amikacin in vitro activity against multiresistant bacteria used singly and in combination with penicillins. Am J Med 1977: 62 Suppl (Jun): 46–52
- Pijck J, Hallynck T, Soep H, et al. Pharmacokinetics of amikacin in patients with renal insufficiency: relation of half-life and creatinine clearance. J Infect Dis 1976: 134 Suppl (Nov): S331–41
- Noone P, Parsons TM, Pattison JR, et al. Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J 1974: 1(Mar): 477–81
- Anderson ET, Young LS, Hewitt WL. Simultaneous antibiotic levels in ‘breakthrough’ gram-negative rod bacteremia. Am J Med 1976: 61(4): 493–7
- Zaske DE, Bootman JL, Solem LB, et al. Increased burn patient survival with individualized dosages of gentamicin. Surgery 1982: 91(2): 142–9
- Cipolle RJ, Selfert RD, Zaske DE, et al. Hospital acquired gram-negative pneumonias: response rate and dosage requirements with individualized tobramycin therapy. Ther Drug Monit 1980: 2(4): 359–63
- Smith CR, Lipsky JJ, Lietman PS, et al. Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity. Antimicrob Agents Chemother 1979: 15(6): 780–2
- Dahlgren JG, Anderson ET, Hewitt WL. Gentamicin blood levels: a guide to nephrotoxicity. Antimicrob Agents Chemother 1975: 8(1): 58–62
- Lesar TS, Rotschafer JC, Strand LM, et al. Gentamicin dosing errors with four commonly used nomograms. JAMA 1982: 248(10): 1190–3
- Zaske DE, Cipolle RJ, Rotschafer JC, et al. Gentamicin pharmacokinetics in 1640 patients: method for control of serum concentrations. Antimicrob Agents Chemother 1982: 21(3): 407–11
- Anderson AC, Hodges GR, Barnes WG. Determination of serum gentamicin sulfate levels: ordering patterns and use as a guide to therapy. Arch Intern Med 1976: 136(7): 785–7